Analysts predict that Castlight Health Inc (NYSE:CSLT) will report $36.02 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Castlight Health’s earnings, with estimates ranging from $36.00 million to $36.03 million. Castlight Health posted sales of $27.75 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 29.8%. The company is expected to issue its next quarterly earnings report on Wednesday, April 25th.
On average, analysts expect that Castlight Health will report full-year sales of $36.02 million for the current year, with estimates ranging from $152.40 million to $153.67 million. For the next financial year, analysts forecast that the business will report sales of $179.05 million per share, with estimates ranging from $175.00 million to $183.54 million. Zacks’ sales calculations are an average based on a survey of research firms that cover Castlight Health.
Castlight Health (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, February 21st. The software maker reported ($0.04) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.05) by $0.01. The business had revenue of $37.00 million during the quarter, compared to the consensus estimate of $36.36 million. Castlight Health had a negative return on equity of 28.76% and a negative net margin of 42.28%. The business’s revenue for the quarter was up 23.7% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.01) earnings per share.
Shares of Castlight Health (NYSE CSLT) traded down $0.15 during trading hours on Friday, hitting $3.70. The stock had a trading volume of 388,725 shares, compared to its average volume of 331,856. The stock has a market capitalization of $514.04, a P/E ratio of -8.22 and a beta of 1.49. The company has a debt-to-equity ratio of 0.03, a quick ratio of 2.06 and a current ratio of 2.06. Castlight Health has a twelve month low of $3.10 and a twelve month high of $4.75.
In other Castlight Health news, CFO Mangini Siobhan Nolan sold 18,201 shares of the business’s stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $3.63, for a total transaction of $66,069.63. Following the completion of the sale, the chief financial officer now owns 120,788 shares of the company’s stock, valued at $438,460.44. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO John C. Doyle sold 10,644 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $3.63, for a total value of $38,637.72. Following the sale, the chief executive officer now directly owns 157,422 shares of the company’s stock, valued at approximately $571,441.86. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,184 shares of company stock valued at $120,762. 24.38% of the stock is owned by company insiders.
Several institutional investors and hedge funds have recently modified their holdings of the business. MetLife Investment Advisors LLC acquired a new position in shares of Castlight Health during the fourth quarter worth about $126,000. Deutsche Bank AG lifted its stake in shares of Castlight Health by 149.1% during the fourth quarter. Deutsche Bank AG now owns 142,486 shares of the software maker’s stock worth $533,000 after purchasing an additional 85,297 shares in the last quarter. Folger Hill Asset Management LP acquired a new position in shares of Castlight Health during the fourth quarter worth about $1,144,000. Geode Capital Management LLC lifted its stake in shares of Castlight Health by 4.5% during the fourth quarter. Geode Capital Management LLC now owns 530,130 shares of the software maker’s stock worth $1,987,000 after purchasing an additional 22,817 shares in the last quarter. Finally, BlackRock Inc. lifted its stake in shares of Castlight Health by 1.3% during the fourth quarter. BlackRock Inc. now owns 3,575,033 shares of the software maker’s stock worth $13,406,000 after purchasing an additional 44,923 shares in the last quarter. Institutional investors own 43.80% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was published by Markets Daily and is the sole property of of Markets Daily. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.themarketsdaily.com/2018/03/13/zacks-brokerages-anticipate-castlight-health-inc-cslt-will-post-quarterly-sales-of-36-02-million.html.
About Castlight Health
Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.